Terez Getz in Surprise, Arizona

Medical School: Arizona College Of Osteopathic Medicine Mid Western University
Graduation Year: 2006
The Primary Medical Specialty for Terez Getz is listed as: Family Practice
Approximate Years of Experience: 18
PAC (PECOS ID)#: 3274695606
NPI #: 1750589974
NPI Created On: 07/10/2007
NPI Last Updated Listed as: 04/25/2013
Primary Taxonomy Code: 207Q00000X
License Number:
005044
Listed Gender: Female

Forms of insurance accepted by include, but are not limited to:

• Health Net of Arizona, Inc.
• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Automated urinalysis test
2. Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage
3. Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older
4. Routine ekg using at least 12 leads including interpretation and report
5. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
6. New patient office or other outpatient visit, typically 45 minutes
7. Established patient office or other outpatient visit, typically 15 minutes
8. Established patient office or other outpatient, visit typically 25 minutes
9. Established patient office or other outpatient, visit typically 40 minutes
10. Physician telephone patient service, 11-20 minutes of medical discussion
11. Physician telephone patient service, 21-30 minutes of medical discussion
12. Administration of influenza virus vaccine
13. Administration of pneumococcal vaccine
14. Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment
15. Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
16. Annual alcohol misuse screening, 15 minutes
17. Annual depression screening, 15 minutes
18. Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes
19. Injection, denosumab, 1 mg